Xinhui Chen

Xinhui Chen

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4544874
-
person_outline Xinhui Chen's MOST POPULAR ARTICLES
1-) Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced/metastatic solid tumors or lymphomasF Meric-Bernstam, RF Sweis, FS Hodi, WA Messersmith, RHI Andtbacka, ...Clinical Cancer Research 28 (4), 677-688, 2022712022
2-) Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib studyF Meric-Bernstam, RF Sweis, S Kasper, O Hamid, S Bhatia, R Dummer, ...Clinical Cancer Research 29 (1), 110-121, 2023782023
3-) Intracellular tenofovir and emtricitabine anabolites in genital, rectal, and blood compartments from first dose to steady stateSM Seifert, X Chen, AL Meditz, JR Castillo-Mancilla, EM Gardner, ...AIDS research and human retroviruses 32 (10-11), 981-991, 2016772016
4-) First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced …SA Piha-Paul, R Geva, TJ Tan, DWT Lim, C Hierro, T Doi, O Rahma, ...Journal for immunotherapy of cancer 9 (8), 2021412021
5-) Validation and application of a liquid chromatography-tandem mass spectrometry method to determine the concentrations of sofosbuvir anabolites in cellsJE Rower, LC Jimmerson, X Chen, JH Zheng, A Hodara, LR Bushman, ...Antimicrobial Agents and Chemotherapy 59 (12), 7671-7679, 2015292015